Reduced ACTC1 expression might play a role in the onset of congenital heart disease by inducing cardiomyocyte apoptosis

Circulation Journal

Volumn 74, Issue 11, 2010, Pages 2410-2418

  Jiang, Hong Kun ^a   Qiu, Guang Rong ^a   Li Ling, Jesse ^a   Xin, Na ^a   Sun, Kai Lai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Actin 1; Apoptosis; Bcl 2; Cardiac ; Caspase 3; Congenital heart disease

Indexed keywords

CASPASE 3; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIAC ALPHA ACTIN 1 GENE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FALLOT TETRALOGY; FEMALE; GENE; GENE EXPRESSION; HEART ATRIUM SEPTUM DEFECT; HEART MUSCLE CELL; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HUMAN TISSUE; INFANT; MALE; NEWBORN; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PRESCHOOL CHILD; RAT;

ACTINS; AGE FACTORS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CASPASE 3; CELL LINE; CHILD, PRESCHOOL; CHINA; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HEART DEFECTS, CONGENITAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFANT; INFANT, NEWBORN; MALE; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; TRANSFECTION;

EID: 78349272750     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0234     Document Type: Article

References (35)

1. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997; 15: 30-35.
2. Gelb BD, Tartaglia M. Noonan syndrome and related disorders: Dysregulated RAS-mitogen activated protein kinase signal transduction. Hum Mol Genet 2006; 15: R220-R226.
3. Wiseman FK, Alford KA, Tybulewicz VL, Fisher EM. Down syndrome-- recent progress and future prospects. Hum Mol Genet 2009; 18: R75-R83.
4. Wat MJ, Shchelochkov OA, Holder AM, Breman AM, Dagli A, Bacino C, et al. Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia. Am J Med Genet A 2009; 149A: 1661-1677.
5. Bruneau BG. The developmental genetics of congenital heart disease. Nature 2008; 451: 943-948.
6. Ching YH, Ghosh TK, Cross SJ, Packham EA, Honeyman L, Loughna S, et al. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet 2005; 37: 423-428.
7. Matsson H, Eason J, Bookwalter CS, Klar J, Gustavsson P, Sunnegardh J, et al. Alpha-cardiac actin mutations produce atrial septal defects. Hum Mol Genet 2008; 17: 256-265.
8. Gunning P, O'Neill G, Hardeman E. Tropomyosin-based regulation of the actin cytoskeleton in time and space. Physiol Rev 2008; 88: 1-35.
9. Fedorova E, Zink D. Nuclear architecture and gene regulation. Biochim Biophys Acta 2008; 1783: 2174-2184.
10. Kueh HY, Mitchison TJ. Structural plasticity in actin and tubulin polymer dynamics. Science 2009; 325: 960-963.
11. McNally E, Dellefave L. Sarcomere mutations in cardiogenesis and ventricular noncompaction. Trends Cardiovasc Med 2009; 19: 17-21.
12. Abdelwahid E, Pelliniemi LJ, Szucsik JC, Lessard JL, Jokinen E. Cellular disorganization and extensive apoptosis in the developing heart of mice that lack cardiac muscle alpha-actin: Apparent cause of perinatal death. Pediatr Res 2004; 55: 197-204.
13. Suurmeijer AJ, Clement S, Francesconi A, Bocchi L, Angelini A, Van Veldhuisen DJ, et al. Alpha-actin isoform distribution in normal and failing human heart: A morphological, morphometric, and biochemical study. J Pathol 2003; 199: 387-397.
14. Laing NG. Congenital myopathies. Curr Opin Neurol 2007; 20: 583-589.
15. Capek P, Brdicka R. Hypertrophic cardiomyopathy. Cas Lek Cesk 2006; 145: 93-96; Discussion 96-97.
16. Monserrat L, Hermida-Prieto M, Fernandez X, Rodriguez I, Dumont C, Cazon L, et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J 2007; 28: 1953-1961.
17. Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, et al. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 2008; 117: 2893-2901.
18. Erdogan F, Ullmann R, Chen W, Schubert M, Adolph S, Hultschig C, et al. Characterization of a 5.3 Mb deletion in 15q14 by comparative genomic hybridization using a whole genome "tiling path" BAC array in a girl with heart defect, cleft palate, and developmental delay. Am J Med Genet A 2007; 143: 172-178.
19. Qi X, Yang G, Yang L, Lan Y, Weng T, Wang J, et al. Essential role of Smad4 in maintaining cardiomyocyte proliferation during murine embryonic heart development. Dev Biol 2007; 311: 136-146.
20. Hove JR, Koster RW, Forouhar AS, Acevedo-Bolton G, Fraser SE, Gharib M. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 2003; 421: 172-177.
21. Auman HJ, Coleman H, Riley HE, Olale F, Tsai HJ, Yelon D. Functional modulation of cardiac form through regionally confined cell shape changes. PLoS Biol 2007; 5: e53.
22. Yashiro K, Shiratori H, Hamada H. Haemodynamics determined by a genetic programme govern asymmetric development of the aortic arch. Nature 2007; 450: 285-288.
23. van den Hoff MJ, van den Eijnde SM, Viragh S, Moorman AF. Programmed cell death in the developing heart. Cardiovasc Res 2000; 45: 603-620.
24. Abdelwahid E, Pelliniemi LJ, Jokinen E. Cell death and differentiation in the development of the endocardial cushion of the embryonic heart. Microsc Res Tech 2002; 58: 395-403.
25. Poelmann RE, Gittenberger-de Groot AC. Apoptosis as an instrument in cardiovascular development. Birth Defects Res C Embryo Today 2005; 75: 305-313.
26. Franklin-Tong VE, Gourlay CW. A role for actin in regulating apoptosis/programmed cell death: Evidence spanning yeast, plants and animals. Biochem J 2008; 413: 389-404.
27. Ferrari R, Ceconi C, Campo G, Cangiano E, Cavazza C, Secchiero P, et al. Mechanisms of remodelling: A question of life (stem cell production) and death (myocyte apoptosis). Circ J 2009; 73: 1973-1982.
28. Hosoda T, Kajstura J, Leri A, Anversa P. Mechanisms of myocardial regeneration. Circ J 2010; 74: 13-17.
29. Miura T, Miki T. GSK-3ß, a therapeutic target for cardiomyocyte protection. Circ J 2009; 73: 1184-1192.
30. Yamazaki Y, Tsuruga M, Zhou D, Fujita Y, Shang X, Dang Y, et al. Cytoskeletal disruption accelerates caspase-3 activation and alters the intracellular membrane reorganization in DNA damage-induced apoptosis. Exp Cell Res 2000; 259: 64-78.
31. White SR, Williams P, Wojcik KR, Sun S, Hiemstra PS, Rabe KF, et al. Initiation of apoptosis by actin cytoskeletal derangement in human airway epithelial cells. Am J Respir Cell Mol Biol 2001; 24: 282-294.
32. Odaka C, Sanders ML, Crews P. Jasplakinolide induces apoptosis in various transformed cell lines by a caspase-3-like protease-dependent pathway. Clin Diagn Lab Immunol 2000; 7: 947-952.
33. Martin SS, Leder P. Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2. Mol Cell Biol 2001; 21: 6529-6536.
34. Nishida K, Otsu K. Cell death in heart failure. Circ J 2008; 72(Suppl A): A-17-A-21.
35. Sun CK, Yuen CM, Kao YH, Chang LT, Chua S, Sheu JJ, et al. Propylthiouracil attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Circ J 2009; 73: 1722-1730.